More than 4 million Americans have glaucoma, but only 50% know they have it, according to the Glaucoma Research Foundation. The suspected number of cases worldwide is 65 million.

The Ophthalmic Imaging Research Laboratory specializes in the development and testing of cutting edge ophthalmic imaging devices. These devices can assist in the early detection and diagnosis of glaucoma and retinal diseases. The ophthalmic imaging devices provide highly detailed images of ocular structures at micron scale. These devices assist also in the quantification of ocular structures.

The Laboratory focuses on the use of ophthalmic imaging devices for glaucoma assessment. Micron scale imaging leads to an earlier diagnosis and a higher sensitivity in detecting the progression of the disease. These techniques can improve the patient’s management of the disease and maintain his/her functional vision.

Glaucoma is a group of diseases that can damage the eye's optic nerve. It often results in vision loss and blindness. Glaucoma occurs when the normal fluid pressure inside the eyes slowly rises. However, recent findings now show that glaucoma can occur with normal eye pressure. Glaucoma can steal sight without warning signs or symptoms. Patients can often protect their eyes against serious vision loss by treating the disease in its early stage.